David D Waters
Title
Cited by
Cited by
Year
Intensive lipid lowering with atorvastatin in patients with stable coronary disease
JC LaRosa, SM Grundy, DD Waters, C Shear, P Barter, JC Fruchart, ...
New England Journal of Medicine 352 (14), 1425-1435, 2005
43052005
Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial
GG Schwartz, AG Olsson, MD Ezekowitz, P Ganz, MF Oliver, D Waters, ...
Jama 285 (13), 1711-1718, 2001
34442001
Effects of torcetrapib in patients at high risk for coronary events
PJ Barter, M Caulfield, M Eriksson, SM Grundy, JJP Kastelein, M Komajda, ...
New England journal of medicine 357 (21), 2109-2122, 2007
30952007
2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice …
RH Eckel, JM Jakicic, JD Ard, JM de Jesus, NH Miller, VS Hubbard, ...
Journal of the American College of Cardiology 63 (25 Part B), 2960-2984, 2014
25512014
Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II)
D Grady, D Herrington, V Bittner, R Blumenthal, M Davidson, M Hlatky, ...
Jama 288 (1), 49-57, 2002
21942002
American College of Cardiology clinical expert consensus document on standards for acquisition, measurement and reporting of intravascular ultrasound studies (ivus). A report …
GS Mintz, SE Nissen, WD Anderson, SR Bailey, R Erbel, PJ Fitzgerald, ...
European Journal of Echocardiography 2 (4), 299-313, 2001
21752001
Aspirin, heparin, or both to treat acute unstable angina
P Théroux, H Ouimet, J McCans, JG Latour, P Joly, G Lévy, E Pelletier, ...
New England Journal of Medicine 319 (17), 1105-1111, 1988
16641988
Effects of estrogen replacement on the progression of coronary-artery atherosclerosis
DM Herrington, DM Reboussin, KB Brosnihan, PC Sharp, SA Shumaker, ...
New England Journal of Medicine 343 (8), 522-529, 2000
15892000
Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis
D Preiss, SRK Seshasai, P Welsh, SA Murphy, JE Ho, DD Waters, ...
Jama 305 (24), 2556-2564, 2011
14702011
Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease
B Pitt, D Waters, WV Brown, AJ van Boven, L Schwartz, LM Title, ...
New England Journal of Medicine 341 (2), 70-76, 1999
1242*1999
Prognostic value of exercise testing soon after myocardial infarction
P Théroux, DD Waters, C Halphen, JC Debaisieux, HF Mizgala
New England Journal of Medicine 301 (7), 341-345, 1979
8821979
Effects of monotherapy with an HMG-CoA reductase inhibitor on the progression of coronary atherosclerosis as assessed by serial quantitative arteriography. The Canadian …
D Waters, L Higginson, P Gladstone, B Kimball, M Le May, SJ Boccuzzi, ...
Circulation 89 (3), 959-968, 1994
6731994
Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: a randomized controlled trial
DD Waters, EL Alderman, J Hsia, BV Howard, FR Cobb, WJ Rogers, ...
Jama 288 (19), 2432-2440, 2002
6502002
Effect of lowering LDL cholesterol substantially below currently recommended levels in patients with coronary heart disease and diabetes: the Treating to New Targets (TNT) study
J Shepherd, P Barter, R Carmena, P Deedwania, JC Fruchart, S Haffner, ...
Diabetes Care 29 (6), 1220-1226, 2006
6492006
Progression of atherosclerosis as assessed by carotid intima-media thickness in patients with HIV infection
PY Hsue, JC Lo, A Franklin, AF Bolger, JN Martin, SG Deeks, DD Waters
Circulation 109 (13), 1603-1608, 2004
6452004
A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina. Platelet Receptor Inhibition in Ischemic Syndrome Management
PRISM Study Investigators
N. Engl. J. Med. 338, 1498-1505, 1998
607*1998
Reactivation of unstable angina after the discontinuation of heparin
P Théroux, D Waters, J Lam, M Juneau, J McCans
New England Journal of Medicine 327 (3), 141-145, 1992
5791992
Is there a simple way to identify insulin-resistant individuals at increased risk of cardiovascular disease?
T McLaughlin, G Reaven, F Abbasi, C Lamendola, M Saad, D Waters, ...
The American journal of cardiology 96 (3), 399-404, 2005
5782005
Hyperlipidemia and coronary disease: correction of the increased thrombogenic potential with cholesterol reduction
L Lacoste, JYT Lam, J Hung, G Letchacovski, CB Solymoss, D Waters
Circulation 92 (11), 3172-3177, 1995
5711995
Very low levels of atherogenic lipoproteins and the risk for cardiovascular events: a meta-analysis of statin trials
SM Boekholdt, GK Hovingh, S Mora, BJ Arsenault, P Amarenco, ...
Journal of the American College of Cardiology 64 (5), 485-494, 2014
5392014
The system can't perform the operation now. Try again later.
Articles 1–20